Search results
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 13 hours ago, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer sales...
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via Yahoo News· 4 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received...
FDA grants full approval for Pfizer's cervical cancer drug
New Hampshire Union Leader· 3 days agoThe Food and Drug Administration (FDA) granted full approval for Pfizer'sdrug for treating cervical ...
Southern Nevada oncologists struggling to treat cancer patients during drug shortage
FOX 5 Las Vegas· 2 days agoFor those who get a life-altering diagnosis such as cancer, people seek treatment. This has left...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 20 hours agoMariana, which specializes in the targeted radiation medicines, could receive up to $750 million...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 7 days agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...
GV spinout launches with $67M, counterintuitive idea to ‘overactivate’ cancer - Boston Business...
The Business Journals· 21 hours agoDelphia Therapeutics Inc. is the brainchild of its co-founders and oncology drug developers Kevin...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 19 hours agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact By Reuters
Investing.com· 21 hours agoApart from an impact of about $40 million cut in inventory, Regeneron said changing market dynamics...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 3 days agoFood and Drug Administration (FDA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of...